Overview
Yanling Li practices practicing medicine in Changsha, China.
Their clinical expertise encompasses Mononucleosis, Nasopharyngeal Carcinoma, Thyroid Cancer, and Stroke.
They are actively involved in clinical research, co-authoring 36 peer reviewed articles.
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Frequently Asked Questions about Yanling Li
Is Yanling Li a top-rated expert for Mononucleosis?
MediFind is an objective health platform that identifies experts based on real-world data. Yanling Li is classified as an Experienced expert for Mononucleosis, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.
Does Yanling Li participate in research or clinical trials?
Yes. Yanling Li has published 36 articles and abstracts on conditions like Mononucleosis. You can view a list of Yanling Li's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Experienced
- Burkitt LymphomaLi isExperienced. Learn about Burkitt Lymphoma.
- MononucleosisLi isExperienced. Learn about Mononucleosis.
- Nasopharyngeal Carcinoma
- Stomach CancerLi isExperienced. Learn about Stomach Cancer.
- StrokeLi isExperienced. Learn about Stroke.
- Thyroid CancerLi isExperienced. Learn about Thyroid Cancer.